The US Food and Drug Administration (FDA) and the European Medicines Agency's (EMA) are recommending new safety precautions for ViiV Healthcare's HIV drug dolutegravir.

A new joint platform for parallel consultation will provide advice to medicine developers and facilitate access to medicines for patients The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA) are stepping up their efforts to provide developers of medicines with simultaneous, coordinated advice ...